Cochlear | COH - Loan Capital

Stock Price
250.17
Daily Change
-8.57 -3.31%
Monthly
-4.74%
Yearly
-19.25%
Q1 Forecast
263.64

Cochlear reported AUD193.5M in Loan Capital for its fiscal semester ending in June of 2025.





Loan Capital Change Date
Ansell USD 638.5M 68.1M Jun/2025
Avita Medical AUD 42.24M 1.25M Dec/2024
Cochlear AUD 193.5M 10M Jun/2025
CSL USD 10.69B 1.37B Jun/2025
Fisher Paykel Healthcare NZD 62.6M 4.3M Dec/2025
Healius AUD 1.22B 103M Dec/2024
Integral Diagnostics AUD 341.63M 1.98M Jun/2024
Mayne Pharma AUD 2.66M 153K Jun/2025
Mesoblast USD 102.44M 8.18M Jun/2024
Monash IVF AUD 170.56M 22.71M Jun/2025
Nanosonics AUD 4.26M 1.51M Jun/2025
Polynovo AUD 12.84M 857K Jun/2024
Ramsay Health Care AUD 5.46B 5.23B Jun/2025
Regis Healthcare AUD 3.67M 442K Jun/2025
ResMed USD 403.92M 4.74M Dec/2025
Sigma Healthcare AUD 1.88B 1.75B Dec/2025
Sonic Healthcare AUD 4.19B 333.39M Dec/2024
Telix Pharmaceuticals AUD 551.82M 533.46M Dec/2024